MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$307,959K
Net Income
$31,500K
Net Profit Margin
10.23%
EPS
$0.18
Unit: Thousand (K) dollars
Revenue Breakdown
Nuplazid
Daybue
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
307,959
268,062
283,989
278,633
Cost of product sales
28,316
24,791
26,225
21,647
Research and development
81,555
76,868
84,757
87,829
Selling, general and administrative
160,252
171,019
155,616
133,401
Gain on sale of non-financial asset
-
-
0
-
Total operating expenses
270,123
272,678
266,598
242,877
Income from operations
37,836
-4,616
17,391
35,756
Interest income, net
7,990
8,055
8,332
8,246
Other income
647
542
596
593
Income before income taxes
46,473
3,981
26,319
44,595
Income tax expense
14,973
344
-247,249
-27,184
Net loss
31,500
3,637
273,568
71,779
Basic EPS
0.18
0.02
1.61
0.43
Diluted EPS
0.18
0.02
1.584
0.42
Basic Average Shares
171,603,000
170,517,000
169,953,000
168,836,000
Diluted Average Shares
172,851,000
172,706,000
172,677,000
170,650,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Nuplazid
$183,132K
(8.70%↑ Y/Y)
Daybue
$124,827K
(29.91%↑ Y/Y)
Total revenues
$307,959K
(16.40%↑ Y/Y)
Income from operations
$37,836K
(16.87%↑ Y/Y)
Interest income, net
$7,990K
(10.31%↑ Y/Y)
Other income
$647K
(8.92%↑ Y/Y)
Total operating
expenses
$270,123K
(16.34%↑ Y/Y)
Income before income
taxes
$46,473K
(15.57%↑ Y/Y)
Selling, general and
administrative
$160,252K
(20.03%↑ Y/Y)
Research and development
$81,555K
(4.62%↑ Y/Y)
Cost of product sales
$28,316K
(36.57%↑ Y/Y)
Net loss
$31,500K
(18.13%↑ Y/Y)
Income tax expense
$14,973K
(10.54%↑ Y/Y)
Buy us a coffee
ACADIA PHARMACEUTICALS INC (ACAD)
ACADIA PHARMACEUTICALS INC (ACAD)